Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: Evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo

Journal of Neural Transmission

Volumn 106, Issue 2, 1999, Pages 131-137

  Inoue, O ^a   Wakahara, S ^a   Kobayashi, K ^a   Gee, A ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Dopamine; MK 801; N methylspiperone; Raclopride; Receptors; Vivo

Indexed keywords

3 METHYLSPIPERONE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE; 3-N-METHYLSPIPERONE; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; SALICYLAMIDE DERIVATIVE; SPIPERONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CEREBELLUM; COMPARATIVE STUDY; DRUG EFFECT; KINETICS; METABOLISM; NEOSTRIATUM;

ANIMALS; BINDING SITES; CEREBELLUM; CEREBRAL CORTEX; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; KINETICS; MICE; MODELS, BIOLOGICAL; NEOSTRIATUM; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SPIPERONE;

EID: 0032604335     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050145     Document Type: Article

References (17)

1. Bischoff S, Bittiger H, Krauss J, Vassout A, Waldmeier P (1984) Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment. Eur J Pharmacol 104: 173-176
2. 3H] spiperone binding in vivo in rat brain. J Recept Res 11: 163-175
3. 11C] raclopride and positron emission tomography. J Neurosci 12: 3773-3780
4. 11C] raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13: 350-356
5. Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP (1993b) Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci USA 90: 11816-11820
6. Dewey SL, Smith GS, Logan J, Alexoff D, Ding YS, King P, Pappas N, Brodie JD, Ashby CR Jr (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15: 821-829
7. Gifford AN, Gatley SJ, Ashby CR Jr (1996) Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices. Synapse 22: 232-238
8. 3H] SCH 23390 in vivo. Neuropharmacology 31: 115-121
9. 2H] SCH 23390 induced by MK-801 in the mouse striatum. Neuropharmacology 32: 341-348
10. 123I] beta-CIT by MK-801 in rat brain. Synapse 30: 402-408
11. 3H] quinuclidinyl benzilate binding in rats. Brain Res 171: 473-480
12. Reith J, Cumming P, Giedde A (1998) Enhanced [3H]DOPA and [3H]dopamine turn-over in striatum and frontal cortex in vivo linked to glutamate receptor antagonism. J Neurochem 70: 1979-1985
13. 3H] raclopride in the mouse brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 340: 6-12
14. 3H] raclopride: implications for positron emission tomography of the human brain. Synapse 3: 96-97
15. 11C] raclopride and PET in normal human subjects. Am J Psychiatry 154: 490-496
16. 11C] raclopride in normal human subjects. Neuropsychopharmacolgy 18: 17-25
17. Volkow ND, Fowler JS, Gatley SJ, Logan J, Wang GJ, Ding YS, Dewey S (1996) PET evaluation of the dopamine system of the human brain. J Nucl Med 37: 1242-1256